Clinical-stage Pharmaceutical Company Presents Positive Results From CNS Disorder Study
NLS Pharmaceutics Reports Positive Results from Study KO-874 on Mazindol’s Neuroprotective Effects in Narcoleptic-like Rat Model.
Disclaimer: The following article discusses a business announcement and is for informational purposes only. It should not be construed as financial advice. Always consult with a financial advisor before making any investment decisions.